Capitol Acq III Ut (CLACU) 10.09 $CLACU Capitol

New Post Public Reply Private Reply Replies (0) Message Board

Jun 12, 2016 at 9:06 AM

Capitol Acq III Ut (CLACU) 10.09 $CLACU

Capitol Acquisition Corp. III (Nasdaq:CLACU) to Ring The Nasdaq Stock Market Opening Bell
GlobeNewswire - Wed Dec 16, 9:40AM CST
What:
NDAQ: 65.58 (-0.08), CLACU: 10.09 (+0.21)

Capitol Acquisition Corp. III Securities to Commence Separate Trading
BusinessWire - Tue Dec 01, 5:23PM CST
Capitol Acquisition Corp. III (NASDAQ: CLACU, the "Company"

announced today that separate trading of the shares of common stock and warrants underlying the Company's units would commence on or about December 4, 2015. The common stock and warrants will be listed on the Nasdaq Capital Market under the symbols CLAC and CLACW, respectively. Units not separated will continue to be listed on the Nasdaq Capital Market under the symbol CLACU.
CLACU: 10.09 (+0.21), CLAC: 9.67 (+0.03)

Capitol Acquisition Corp. III Completes $325 Million Initial Public Offering
BusinessWire - Tue Oct 20, 8:07AM CDT
Capitol Acquisition Corp. III (NASDAQ:CLACU) (the "Company"

, an acquisition vehicle formed by investor Mark D. Ein, announced that it has completed its initial public offering of 32,500,000 units, including 2,500,000 units subject to the underwriters' over-allotment option, with the offering raising aggregate gross proceeds of $325,000,000. Each unit consists of one share of common stock and one half of one warrant, each whole warrant to purchase one share of common stock at a price of $11.50.
CLACU: 10.09 (+0.21)

Capitol Acquisition announces increase of IPO proceeds to USD325m
M2 - Fri Oct 16, 3:05AM CDT
Capitol Acquisition Corp III (NASDAQ:CLACU) declared on Friday that with the underwriters having exercised their over-allotment option to buy 2,500,000 additional units at USD10.00 per unit, the proceeds have been raised by USD25m.
CLACU: 10.09 (+0.21), CLA: 24.95 (-0.20)

Capitol Acquisition Corp. III Initial Public Offering Proceeds Increased to $325 million
BusinessWire - Thu Oct 15, 4:15PM CDT
Capitol Acquisition Corp. III (NASDAQ:CLACU, the "Company"

announced today that the underwriters have exercised their over-allotment option to purchase an additional 2,500,000 units at $10.00 per unit, representing $25,000,000 in additional proceeds. As a result, an aggregate of 32,500,000 units have been sold by the Company for total gross proceeds of $325,000,000.
CLACU: 10.09 (+0.21)

Capitol Acquisition prices IPO of USD300m units at USD10.00 per unit
M2 - Wed Oct 14, 4:02AM CDT
Capitol Acquisition Corp III (NASDAQ:CLACU) has priced its initial public offering (IPO) of 30,000,000 units at USD10.00 per unit for total gross proceeds of USD300,000,000, it stated on Wednesday.
CLACU: 10.09 (+0.21), CLA: 24.95 (-0.20)

Capitol Acquisition Corp. III Prices $300 Million Initial Public Offering
BusinessWire - Tue Oct 13, 9:37PM CDT
Capitol Acquisition Corp. III (NASDAQ:CLACU, the "Company"

announced today that it priced its initial public offering of 30,000,000 units at $10.00 per unit for aggregate gross proceeds of $300,000,000. Each unit consists of one share of common stock and one half of one warrant, each whole warrant to purchase one share of common stock at a price of $11.50. The underwriters have been granted a 30-day option to purchase up to an additional 4,500,000 units offered by the Company to cover over-allotments, if any. The units are expected to begin trading on the NASDAQ on October 14, 2015 under the symbol "CLACU."
CLACU: 10.09 (+0.21)

Capitol Acquisition Corp. II Establishes Date of July 8, 2015 for Special Meeting of Stockholders to Approve Merger with Lindblad Expeditions, Inc.
PR Newswire - Wed Jun 24, 7:00AM CDT
Capitol Acquisition Corp. II (NASDAQ: CLAC; "Capitol"

and Lindblad Expeditions, Inc. ("Lindblad" or the "Company"

, a global provider of expedition cruises and adventure travel experiences, today announced the date for the special meeting of stockholders to approve, among other things, the proposed merger between Capitol and Lindblad.
TWO: 8.60 (+0.01), SBY: 16.18 (-0.02), CLACU: 10.09 (+0.21), CLAC: 9.67 (+0.03)

Lindblad Expeditions, Inc. Reports First Quarter 2015 Financial Results
PR Newswire - Wed May 27, 7:00AM CDT
Capitol Acquisition Corp. II (NASDAQ: CLAC; "Capitol"

and Lindblad Expeditions, Inc. ("Lindblad" or the "Company"

, a global provider of expedition cruises and adventure travel experiences, today reported Lindblad's financial results for the quarter ended March 31, 2015.
TWO: 8.60 (+0.01), CLACU: 10.09 (+0.21), CLAC: 9.67 (+0.03)

Capitol Acquisition Corp. II Shareholders Approve Extension to Consummate Merger with Lindblad Expeditions
PR Newswire - Thu May 14, 4:28PM CDT
Capitol Acquisition Corp. II (NASDAQ: CLAC; "Capitol"

today announced that it has received stockholder approval to extend the date by which it must complete a business combination to July 31, 2015 (the "Extension"

.
TWO: 8.60 (+0.01), CLACU: 10.09 (+0.21), CLAC: 9.67 (+0.03)

Lindblad Expeditions, Inc. Closes $150 Million Debt Financing
PR Newswire - Mon May 11, 7:00AM CDT
Capitol Acquisition Corp. II (NASDAQ: CLAC; "Capitol"

today announced that Lindblad Expeditions, Inc. ("Lindblad"

, Capitol's proposed merger partner, has entered into its previously announced new Credit Agreement with Credit Suisse A.G. as Administrative Agent and Collateral Agent. The financing was increased from $120.0 to $150.0 million in size and the incremental proceeds will be used for general corporate purposes. Lindblad has applied the remaining net proceeds from the financing to repay its existing debt and complete the buyout of certain existing stakeholders.
TWO: 8.60 (+0.01), CLACU: 10.09 (+0.21), CLAC: 9.67 (+0.03)

Capitol Acquisition Corp. II Seeks Extension to Consummate Merger with Lindblad Expeditions
PR Newswire - Mon May 04, 5:30AM CDT
Capitol Acquisition Corp. II (NASDAQ: CLAC; "Capitol"

today announced that it will seek stockholder approval to extend the date by which Capitol must complete a business combination (the "Extension"

.
TWO: 8.60 (+0.01), CLACU: 10.09 (+0.21), CLAC: 9.67 (+0.03)

Capitol Acquisition Corp. II to Merge with Lindblad Expeditions
PR Newswire - Tue Mar 10, 6:01AM CDT
Lindblad Expeditions, Inc. ("Lindblad"

, a global leader in expedition cruising and extraordinary adventure travel experiences, and Capitol Acquisition Corp. II (NASDAQ: CLAC; "Capitol"

, a public investment vehicle formed for the purpose of effecting a merger, acquisition or similar business combination, announced that they have entered into a definitive agreement to merge in a transaction valued at approximately $439 million. The combined company intends to be listed on the NASDAQ Stock Market and be renamed Lindblad Expeditions Holdings, Inc. following completion of the merger. The combined company will continue to be led by Lindblad President and Founder Sven-Olof Lindblad and the current Lindblad management team.
TWO: 8.60 (+0.01), CLACU: 10.09 (+0.21), CLAC: 9.67 (+0.03)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ortho Molecular and HANS: Streamlining Functional Medicine

Functional Medicine Gets a Tech Boost The world of functional medicine just got a major shot in the arm, courtesy of an intriguing alliance between Ortho Molecular Products and HANS.FM. First of all, let's address the elephant in the room: clinicians in this field aren't exactly on a coffee break. They’re buried under mountains of paperwork, often spending hours just...

CURE Intl and Thoughtworks Step Into Digital Era

Pushing Paper Out, Digitizing In In a world where tech is king, why were hospitals—crucial, life-saving institutions—still bogged down by dusty folders and ink smudges? Well, not anymore for CURE International, not with Thoughtworks stepping up to the plate. This ain't just swapping paper for pixels; it's a lifeline for kids getting world-class surgical care without...

Jinko Solar Joins B20 Summit: Energy Forefront Focus

Jinko Solar's Invitation to the B20 Summit Never a dull moment in the solar space, especially when Jinko Solar, a big shot in clean energy, jumps into the spotlight at the B20 Summit in the U.S. Awash with high-profile discussions, Jinko's not just chatting—it's the only photovoltaic firm strutting its stuff in D.C. with gutsy calls for energy reform. Key Takeaways from...

Jubilant Eyes MPN Breakthrough with JBI-802 Data at ASH

Presenting the Case for JBI-802 From the bustling circus of drug development, here comes Jubilant Therapeutics, strutting their stuff with JBI-802, a dual inhibitor designed to tackle myeloproliferative neoplasms (MPNs) with a one-two punch. Now, they're set to drop some spicy deets at the 68th ASH Annual Meeting in New Orleans this December. So what's the fuss about?...

Agilyx's Q3 Update: GreenDot Shines Amid Mixed Results

Peeking into Agilyx's Financial Odyssey Just as I sip my morning coffee pondering the highs and lows of the market, here comes Agilyx ASA splashing some liquidity on the scene. The Q3 report paints the company in various shades—from solid greens to hesitant reds. Nothing like the thrill of untangling mixed results over a quiet day, huh? GreenDot's Climb to Profitability...

Inflatable Wonders Turn Christmas into a Hoot at Lowe's

Inflatables Bringing the Cheer (and Laughs) Well, it's that season again—where decorations either have us grumbling at the electric bill or chuckling at the lawn art. Lowe's has teamed up with Gemmy to serve a heaping platter of holiday giggles this year. They've rolled out a quirky lineup of inflatables that go from shivering Highland cows to dinosaurs and elves....

LG Innotek Scores Hat Trick with CES Innovation Wins

LG Innotek's Lighting Triumph Here we go again, LG Innotek just snagged their third CES Innovation Award in a row, this time for their cutting-edge vehicle lighting module, Nexlide C+. It's one for the books—breaking into the 2027 CES spotlight with innovative tech that not only grabs the eyes but could also steal the hearts of investors willing to bet on the future of...

RF MEDICAL Expands into Europe with New CE Certification

RF MEDICAL Secures CE Marking for Mi-BLATOR™ Just when you think the European medical device market's hit its saturation point, RF MEDICAL decides to kick the door open with their Mi-BLATOR™ microwave ablation system. This ain't just another plastic gadget, folks; it's got that shiny new CE marking under the European Union's Medical Device Regulation (MDR). Now, what...

BD Sets Stage for Investor Day in December 2026

BD's Investor Day: A Peek into the Future Say what you will about investor meets, but BD (Becton, Dickinson and Company) throwing its shindig on December 10, 2026, could be a highlight on the calendar if you're eyeing the medical technology sector. Scheduled in New York, this event is gearing up to be a canvas for BD's higher-ups to sketch out their roadmap. If you’re...

Centrus Energy Welcomes Nuclear Veteran to Leadership

Navigating a New Era at Centrus When you hear about seasoned veterans stepping up to the plate in the energy sector, it's time to perk up your ears. Centrus Energy (NYSE:LEU), a big player in nuclear fuel, just added Kevin Graney to their Board of Directors. This isn't your run-of-the-mill appointment; it packs nearly three decades of nuclear tech and national security...